Caryn McDowell
Nessuna posizione attualmente
Storia della carriera di Caryn McDowell
Precedenti posizioni note di Caryn McDowell
Società | Posizione | Inizio | Fine |
---|---|---|---|
QUINCE THERAPEUTICS, INC. | Direttore Amministrativo | 11/05/2020 | 08/07/2022 |
Consigliere Generale | 11/05/2020 | 08/07/2022 | |
Segretario Aziendale | 11/05/2020 | 08/07/2022 | |
CYTOKINETICS, INCORPORATED | Responsabile della Conformità | 18/05/2016 | 01/05/2018 |
Consigliere Generale | 01/05/2015 | 01/05/2018 | |
INTERMUNE INC | Corporate Officer/Principal | 01/01/2014 | 01/02/2015 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Consigliere Generale | 01/06/2013 | 01/12/2013 |
AFFYMAX, INC. | Consigliere Generale | 01/01/2012 | 01/01/2013 |
US Department of Health & Human Services (DC) | Corporate Officer/Principal | 01/01/2001 | 01/01/2004 |
REVANCE THERAPEUTICS, INC. | Consigliere Generale | 01/05/2018 | - |
Segretario Aziendale | 01/05/2018 | - | |
State of Massachusetts | Corporate Officer/Principal | - | - |
Formazione di Caryn McDowell
University of Michigan | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
General Counsel | 5 |
Corporate Officer/Principal | 3 |
Corporate Secretary | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Government | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
CYTOKINETICS, INCORPORATED | Health Technology |
AFFYMAX, INC. | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
QUINCE THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
US Department of Health & Human Services (DC) | Government |
State of Massachusetts | Government |
- Borsa valori
- Insiders
- Caryn McDowell
- Esperienza